Cargando…
Reversal agents for oral anticoagulant-associated major or life-threatening bleeding
Oral anticoagulants (OA) are effective drugs for treating and preventing the formation of blood clots in patients with atrial fibrillation, mechanical heart valves and venous thromboembolism but their therapeutic effect is always counterbalanced by an increased risk of bleeding. Direct oral anticoag...
Autores principales: | Moia, Marco, Squizzato, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881427/ https://www.ncbi.nlm.nih.gov/pubmed/31446606 http://dx.doi.org/10.1007/s11739-019-02177-2 |
Ejemplares similares
-
Correction to: Reversal agents for oral anticoagulant-associated major or life-threatening bleeding
por: Moia, Marco, et al.
Publicado: (2019) -
Managing anticoagulation in the COVID-19 era between lockdown and reopening phases
por: Poli, Daniela, et al.
Publicado: (2020) -
Vitamin K antagonist therapy: changes in the treated populations and in management results in Italian anticoagulation clinics compared with those recorded 20 years ago
por: Palareti, Gualtiero, et al.
Publicado: (2017) -
Efficacy and safety of direct oral anticoagulants in older adults with atrial fibrillation: a prospective single-centre cohort study
por: Catalani, Filippo, et al.
Publicado: (2023) -
Costs and Healthcare Resource Utilization Associated with Idarucizumab or Andexanet Alfa Oral Anticoagulant Reversal in Patients Hospitalized with Life-Threatening Bleeds
por: Spyropoulos, Alex C., et al.
Publicado: (2022)